A61K 2039/70
Multivalent vaccine
Official title: {Multivalent vaccine}
A61K2039/70 (Multivalent vaccine) appears on 1,995 US grants and 3,419 published applications in this corpus.
Search patents in A61K- Granted patents
- 1,995
- Published applications
- 3,419
- Assignees
- 1,294
- Inventors
- 5,753
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 4 | 0 |
| 1977 | 2 | 0 |
| 1978 | 3 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 4 | 0 |
| 1983 | 0 | 0 |
| 1984 | 2 | 0 |
| 1985 | 6 | 0 |
| 1986 | 6 | 0 |
| 1987 | 7 | 0 |
| 1988 | 5 | 0 |
| 1989 | 2 | 0 |
| 1990 | 2 | 0 |
| 1991 | 5 | 0 |
| 1992 | 4 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 6 | 0 |
| 1997 | 12 | 0 |
| 1998 | 16 | 0 |
| 1999 | 15 | 0 |
| 2000 | 12 | 0 |
| 2001 | 14 | 5 |
| 2002 | 23 | 25 |
| 2003 | 22 | 47 |
| 2004 | 16 | 47 |
| 2005 | 12 | 44 |
| 2006 | 16 | 53 |
| 2007 | 19 | 59 |
| 2008 | 25 | 76 |
| 2009 | 31 | 85 |
| 2010 | 34 | 93 |
| 2011 | 32 | 87 |
| 2012 | 32 | 87 |
| 2013 | 32 | 97 |
| 2014 | 75 | 147 |
| 2015 | 81 | 175 |
| 2016 | 111 | 184 |
| 2017 | 130 | 196 |
| 2018 | 165 | 204 |
| 2019 | 156 | 174 |
| 2020 | 154 | 199 |
| 2021 | 128 | 211 |
| 2022 | 112 | 206 |
| 2023 | 117 | 244 |
| 2024 | 123 | 269 |
| 2025 | 146 | 217 |
| 2026 | 69 | 188 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Variant strain-based coronavirus vaccines22 Sep 2026US 12,741,019 B2ModernaTX, Inc.
- Vaccines, vaccine priming, and antigen dose sparing22 Sep 2026US 12,741,022 B2Adjuvance Technologies, Inc.
- Fusion peptide vaccines15 Sep 2026US 12,734,225 B2Treos Bio Limited
- Staphylococcus aureus vaccine compositions15 Sep 2026US 12,734,227 B2New York University
- Autologous cancer tumour associated extrachromosomal circular DNA for use as a therapeutic vaccine8 Sep 2026US 12,728,157 B2Circular Biotech AB
- Modular multiplatform system for mrna drug production8 Oct 2026US 2026/0306407 A1BioNTech SE
- Systems and Methods for Delivery of Viral Antigens8 Oct 2026US 2026/0306610 A1Veergen Inc.
- Differential coating of microprojections and microneedles on arrays8 Oct 2026US 2026/0306611 A1Vaxxas Pty Limited
- Combination Vaccine8 Oct 2026US 2026/0306615 A1Seqirus Inc.
- A vaccine against erysipelothrix rhusiopathiae and porcine parvo virus8 Oct 2026US 2026/0306618 A1Intervet Inc.
Most cited
By later US patents
- Application of mRNA for use as a therapeutic agent for tumorous diseases194US 8,217,016 B2CureVac AG · 2012
- Vaccine comprising a baculovirus produced influenza hemagglutinin protein fused to a second protein146US 5,858,368 AProtein Sciences Corporation · 1999
- Method for producing influenza hemagglutinin multivalent vaccines using baculovirus139US 5,762,939 AMg-Pmc, LLC · 1998
- Preservation of viruses124US 5,149,653 AQuadrant Bioresources Limited · 1992
- Combination PIV3/hMPV RNA vaccines110US 10,064,934 B2ModernaTX, Inc. · 2018